Cue Biopharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cue Biopharma and other ETFs, options, and stocks.About CUE
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology).
CUE Key Statistics
Stock Snapshot
As of today, Cue Biopharma(CUE) shares are valued at $0.30. The company's market cap stands at 27.65M, with a P/E ratio of -0.66.
During the trading session on 2026-02-13, Cue Biopharma(CUE) shares reached a daily high of $0.32 and a low of $0.30. At a current price of $0.30, the stock is +2.2% higher than the low and still -5.5% under the high.
Trading volume for Cue Biopharma(CUE) stock has reached 54.72K, versus its average volume of 480.07K.
Over the past 52 weeks, Cue Biopharma(CUE) stock has traded between a high of $1.54 and a low of $0.23.
Over the past 52 weeks, Cue Biopharma(CUE) stock has traded between a high of $1.54 and a low of $0.23.
CUE News
Cue Biopharma ( (CUE) ) has issued an announcement. On February 9, 2026, Cue Biopharma’s board appointed Chief Business Officer Lucinda Warren as Chief Financi...
Cue Biopharm announced that Lucinda Warren, who has served as Cue Biopharma’s (CUE) chief business officer, CBO, since September 2024, has been appointed chief...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.